Cardinal Health expands ability to make molecular imaging agents

Cardinal Health Inc. (NYSE: CAH) will manage and operate the Knoxville, Tennessee, cyclotron facility of ProVision Healthcare through an agreement that expands the Dublin, Ohio, drug distributor’s ability to make molecular imaging agents nationwide. Ohio’s largest corporation has been partnering with academia and industry to push the boundaries of nuclear medicine — and have first dibs on …

This entry was posted in Molecular Medicine. Bookmark the permalink.

Comments are closed.